Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions

The move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication's cost for seniors on Medicare.

Eli Lilly will cap the out-of-pocket cost of its insulin at $35 a month, the drugmaker said Wednesday. The move, experts say, could prompt other insulin makers in the U.S. to follow suit.

The change, which Eli Lilly said takes effect immediately, puts the drugmaker in line with a provision in the Inflation Reduction Act, which in January imposed a $35 monthly cap on the out-of-pocket cost of insulin for seniors enrolled in Medicare.

https://www.nbcnews.com/health/health-news/eli-lilly-caps-cost-insulin-35-month-rcna72713